Creon 12000 [USP'U]/1

Creon 12000 [USP'U]/1 is a delayed-release pancreatic enzyme supplement designed to aid digestion. It contains pancrelipase, which helps break down fats, proteins, and carbohydrates. Ideal for those with exocrine pancreatic insufficiency, this medication supports nutrient absorption and digestive health.

Creon 12000 [USP'U]/1 is primarily used to manage exocrine pancreatic insufficiency, a condition where the pancreas does not produce enough digestive enzymes. This supplement helps break down fats, proteins, and carbohydrates, facilitating nutrient absorption and alleviating digestive discomfort. It is often prescribed for conditions like chronic pancreatitis or cystic fibrosis, where the pancreas cannot produce sufficient enzymes for proper digestion.

Creon 12000 [USP'U]/1 works by releasing digestive enzymes in the small intestine, where they help break down food. Users may experience improved digestion and reduced symptoms like bloating, gas, and fatty stools. The delayed-release pellets ensure that the enzymes are released at the appropriate site in the digestive tract for optimal effectiveness.

Creon 12000 [USP'U]/1 should be taken with meals or snacks and swallowed whole, not chewed or crushed. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Keep the capsules in a cool, dry place and ensure they are stored properly to maintain their effectiveness.

Creon 12000 [USP'U]/1 may interact with certain medications, including antacids and other digestive aids. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, the medication should be used with caution in individuals with known allergies to pork proteins, as pancrelipase is derived from porcine sources.